On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

The agent for Bobby Portis is calling the Milwaukee Bucks forward's use of Tramadol, the drug that has led to his suspension, ...

The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid painkiller for treating moderate to severe pain in what the FDA considered the ...

the acting director of the FDA's Center for Drug Evaluation and Research, said in a statement. “A new non-opioid analgesic therapeutic class for acute pain offers an opportunity to mitigate ...

Millions of Brits can avoid the lengthy wait to see their GP if they have one of 16 health conditions that can now be treated using a new Online Doctor service.

Certain drugs and a host of nonpharmacologic therapies are key to treating patients who have nociplastic pain, a relatively ...

New govt regulations and policies are pushing pharmaceutical sector in the right direction, says Highnoon Labs chairman.

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

The increasing availability of these and other synthetic drugs led the UK’s National Crime Agency (NCA) to warn in August ...

More than trade and tariff matters, it would be interesting to know where New Delhi stands with regards to the White House and Trump’s agenda on illegal immigrants.

Light AI Inc. ("Light AI" or the "Company") (CBOE CA: ALGO / FSE: 0HC), a global healthcare technology company focused on developing artificial intelligence health diagnostic and wellness solutions, ...